Breaking News, Financial News

Financial Report: Allergan

Revenues up 17% in the quarter, plans to cut 13% of workforce

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Allergan   2Q Revenues: $1.9 billion (+17%) 2Q Earnings: $418.4 million  (+15%) YTD Revenues: $3.4 billion (+15%) YTD Earnings: $676.3 million (+80%) Comments: Total specialty pharmaceutical sales were $1.5 billion in the quarter, up 13%. Eye Care Pharmaceutical sales were $827 million, up 15%. Botox/Neuromodulators sales were $579.4 million, up 13%. Skin Care and other sales were $119.7 million, up 7%. YTD13 earnings included $259 million in costs associated with discontinued operations. Al...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters